Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Besremi (ropeginterferon alfa-2B) to Treat Polycythaemia Vera

Besremi® (ropeginterferon alfa-2B) is the first approved mono-pegylated proline interferon indicated for the treatment of polycythaemia vera. Image courtesy of National Library of Medicine, National Institutes of Health, Health & Human Services.



  • Besremi®
  • Besremi®
  • Besremi®

Go Top